Rabbit Recombinant Monoclonal JAML antibody. Suitable for IP, WB and reacts with Human, Rat, Mouse samples. Cited in 5 publications.
View Alternative Names
AMICA1, UNQ722/PRO1387, JAML, Junctional adhesion molecule-like, Adhesion molecule interacting with CXADR antigen 1, Dendritic cell-specific protein CREA7-1
- IP
Supplier Data
Immunoprecipitation - Anti-JAML antibody [EPR15289] (AB183714)
Western blot analysis of JAML in 293 cell lysate immunoprecipitated using ab183714 at 1/50 dilution (Lane 1). Lane 2 : TBS instead of 293 lysate.
Secondary antibody : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution
All lanes:
Immunoprecipitation - Anti-JAML antibody [EPR15289] (ab183714)
Predicted band size: 44 kDa
false
- WB
Supplier Data
Western blot - Anti-JAML antibody [EPR15289] (AB183714)
All lanes:
Western blot - Anti-JAML antibody [EPR15289] (ab183714) at 1/20000 dilution
Lane 1:
Human fetal liver lysate at 20 µg
Lane 2:
Jurkat cell lysate at 20 µg
Lane 3:
Molt-4 cell lysate at 20 µg
Lane 4:
293 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 44 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-JAML antibody [EPR15289] (AB183714)
All lanes:
Western blot - Anti-JAML antibody [EPR15289] (ab183714) at 1/5000 dilution
Lane 1:
C6 (rat glioma cell line) whole cell lysate at 10 µg
Lane 2:
RAW 264.7 (mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate at 1/1000 dilution
Predicted band size: 44 kDa
Observed band size: 60 kDa
false
Related conjugates and formulations (1)
-
Anti-JAML antibody [EPR15289] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Beyond serving as a simple structural component JAML establishes interactions critical for immune surveillance and cell movement. It pairs with other immune receptors to promote the transmigration of leukocytes across endothelial and epithelial barriers. This interaction is notably important since JAML mediates adhesion through its engagement with the Coxsackievirus and Adenovirus Receptor (CAR) forming dynamic complexes that facilitate immune cell trafficking.
Pathways
Many cellular processes engage JAML in key signaling pathways responsible for immune responses. The protein takes part in the integrin signaling pathway affecting cellular adhesion and migration. Additionally JAML interacts with LFA-1 (Lymphocyte Function-associated Antigen 1) an integrin involved in leukocyte function modulating pathways that govern immune cell behavior and inflammation responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 37:212-226 PubMed40353078
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:24514 PubMed39424882
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 24:257 PubMed38982456
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 20:260 PubMed35672776
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:565676 PubMed33777731
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com